Bulk Inquiry
UNBS5162
- Soluble in 0.1N HCl(aq) and DMSO
- MF: C17H18N4O3
- MW: 326.35
Description
UNBS5162 is a pan-antagonist of CXCL chemokine expression, displaying antitumor effects in experimental models of human refractory prostate cancer.
More Information
| Parent CAS No. | 956590-23-1 |
|---|---|
| Chemical Name | 1-(2-(2-(Dimethylamino)ethyl)-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-5-yl)urea |
| SMILES | C1C2C(=O)N(CCN(C)C)C(=O)C3C=2C(C=C(NC(=O)N)C=3)=CC=1 |
| MFCD | N.A. |
| InChi | InChI=1S/C17H18N4O3/c1-20(2)6-7-21-15(22)12-5-3-4-10-8-11(19-17(18)24)9-13(14(10)12)16(21)23/h3-5,8-9H,6-7H2,1-2H3,(H3,18,19,24) |
| InChiKey | WCKZRLOUKYFJDY-UHFFFAOYSA-N |
| CID | 16048966 |
| Short Description | CXCL antagonist |
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 1179 | A1B1 hydrochloride |
From $137.50 |
| 1559 | SB 265610 |
From $132.00 |
| 1620 | WZ 811 |
From $88.00 |
| 1738 | AMD 3100 |
From $99.00 |
| 1800 | CXCR3 Antagonist 6c |
From $148.50 |
| 1930 | AMD 3465 hexahydrobromide |
From $93.50 |
| 2082 | BX 471 |
From $115.50 |
| 2255 | AZD8797 |
From $132.00 |
| 2593 | SB 332235 |
From $115.50 |
| 2636 | YJC-10592 |
From $159.50 |
| 2665 | Cenicriviroc |
From $176.00 |
| 2685 | Vercirnon |
From $148.50 |
| 2842 | AZD2098 |
From $137.50 |
| 2861 | ZK 756326 dihydrochloride |
From $99.00 |
| 2921 | LIT-927 |
From $104.50 |
| 3774 | LN6023 dihydrochloride |
From $165.00 |
